Thousands flee Ebola-hit camp as DR Congo tests preventive drug
publishers 49articles 55first reported 1 Oct, 16:11 UTCdeveloping since 2 Oct · 29 editions
Thousands of people have fled an Ebola-hit camp in the Democratic Republic of Congo, raising concerns that the virus could spread further, Reuters reported.
Authorities in the country said more than 4,000 deaths have been recorded in the outbreak, according to Sky News.
DR Congo is also testing obeldesivir as a treatment intended to reduce the risk of Ebola infection after exposure. More than 250 people have enrolled in the prevention trial, according to reports citing PBS NewsHour. Several outlets identified the experimental drug as a Gilead product.
The trial and the movement of people from the affected camp come as authorities struggle to contain the virus.
HOW THIS STORY WAS MADE
Written from 8 articles, 1 with the publisher's own text; 8 independent newsrooms once syndicated copies count as one; this version written 84 h after the record first saw the story; the editor revised it.
- Publishers
- 49
- Source articles
- 55
- Given to the writer
- 8, 1 with the article's own text
- Independent newsrooms
- 8
- This version written
- 84 h after the record first saw the story
- Second model (editor)
- revised
- Publication gate
- passed
- Human review
- none
WHAT THE EDITOR DID
The second model checked the writer's draft against the same sources and changed it before publication. Struck words were in the draft; underlined words are its corrections.
WHAT IT FLAGGED editor revise: Remove commentary about missing source details so the story sticks to reported facts. - "The reports did not provide further details on where those deaths occurred or the period over which they were counted.": This is commentary about what the sources did not say, not reported news. - "Details about the trial’s design, preliminary results and expected completion date were not reported.": This is commentary about what the sources did not say, not reported news. - "No information was provided on where those who left the camp had gone or what monitoring measures were being used.": This is commentary about what the sources did not say, not reported news.
THE DRAFT AND THE CHANGES
Thousands flee Ebola-hit camp as DR Congo tests preventive drug
Thousands of people have fled an Ebola-hit camp in the Democratic Republic of Congo, raising concerns that the virus could spread further, Reuters reported.
Authorities in the country said more than 4,000 deaths have been recorded in the outbreak, according to Sky News. The reports did not provide further details on where those deaths occurred or the period over which they were counted.
DR Congo is also testing obeldesivir as a treatment intended to reduce the risk of Ebola infection after exposure. More than 250 people have enrolled in the prevention trial, according to reports citing PBS NewsHour. Several outlets identified the experimental drug as a Gilead product.
The trial and the movement of people from the affected camp come as authorities struggle to contain the virus. Details about the trial’s design, preliminary results and expected completion date were not reported. No information was provided on where those who left the camp had gone or what monitoring measures were being used.
Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →